No Data
No Data
What 4 Analyst Ratings Have To Say About Bluebird Bio
Bluebird Bio Shares Are Trading Lower After JP Morgan Downgraded the Stock From Overweight to Neutral and Multiple Firms Lowered Their Respective Price Targets on the Stock.
RBC Capital Maintains Bluebird Bio(BLUE.US) With Hold Rating, Maintains Target Price $4
Bluebird Bio Price Target Maintained With a $4.00/Share by RBC Capital
Bluebird Bio Is Maintained at Overweight by Barclays
BofA Securities Maintains Bluebird Bio(BLUE.US) With Buy Rating, Maintains Target Price $3
74608670 : Just buy it for a hundred dollars and take a look![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)